Artiva Biotherapeutics, Inc. is a clinical-stage biotechnology company developing allogeneic natural killer (NK) cell-based therapies for autoimmune diseases and cancers. Its lead product candidate, AlloNK, is in clinical development targeting conditions including rheumatoid arthritis, lupus nephritis, Sjögren's disease, and other autoimmune diseases. Product candidates are derived from donor cells, pre-manufactured, stored frozen, and ready to use. The company operates its own clinical manufacturing facility in San Diego, California.
expected 2026-12-11
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-10 | 2025-12-31 | 0001193125-26-100135 | EDGAR | 124K words |
| 2025-03-24 | 2024-12-31 | 0000950170-25-043837 | EDGAR | 131K words |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-08-06 | 2026-06-30 | 0001193125-26-338029 | EDGAR | 79K words |
| 2025-11-12 | 2025-09-30 | 0001193125-25-275872 | EDGAR | 80K words |
| 2025-08-06 | 2025-06-30 | 0000950170-25-104045 | EDGAR | 79K words |
| 2025-05-08 | 2025-03-31 | 0000950170-25-066421 | EDGAR | 76K words |
| 2024-11-12 | 2024-09-30 | 0000950170-24-125382 | EDGAR | 80K words |
| 2024-08-29 | 2024-06-30 | 0001193125-24-209924 | EDGAR | 81K words |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-09-11 | 0001193125-26-389308 | EDGAR | 19K words |
| 2026-08-06 | 0001193125-26-337986 | EDGAR | 2K words |
| 2026-07-22 | 0001193125-26-312560 | EDGAR | 1K words |
| 2026-03-10 | 0001193125-26-100131 | EDGAR | 2K words |
| 2026-02-24 | 0001193125-26-067509 | EDGAR | 1K words |
| 2026-02-19 | 0001193125-26-059716 | EDGAR | 1K words |
| 2025-12-12 | 0001193125-25-317784 | EDGAR | 1K words |
| 2025-11-12 | 0001193125-25-275902 | EDGAR | 2K words |
| 2025-11-12 | 0001193125-25-275867 | EDGAR | 2K words |
| 2025-08-06 | 0000950170-25-104028 | EDGAR | 2K words |
35 total filings indexed. 17 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001817241 |
| Ticker | ARTV |
| Exchange | Nasdaq |
| SIC | 2836: Biological Products, (No Diagnostic Substances) |
| Incorporated | DE |
| Headquarters | San Diego, California |
| Website | https://www.artivabio.com |
| Listed | 2024-07-19 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/ARTV (~200 tokens, structured JSON with cryptographic provenance)